Item 5.07 Submission of Matters to a Vote of Security Holders.

Armata Pharmaceuticals, Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting") on December 8, 2020, at 8:30 a.m. local time at the Company's headquarters in Marina del Rey, California. At the Annual Meeting, stockholders voted on the matters disclosed in the Company's definitive proxy statement filed with the Securities and Exchange Commission on October 22, 2020. The final voting results for the matters submitted to a vote of stockholders are provided below

Proposal 1 - Election of directors:

All of the Company's director nominees were elected for a one-year term expiring at the 2021 Annual Meeting of Shareholders.





                           Votes For    Votes Withheld   Broker Non-Votes
Todd R. Patrick            12,837,561       13,793          1,124,364

Richard J. Bastiani, Ph.D. 12,836,461 14,893 1,124,364 Sarah J. Schlesinger, M.D. 12,825,302 26,052 1,124,364 Joseph M. Patti, Ph.D. 12,837,567 13,787 1,124,364 Odysseas D. Kostas, M.D. 12,838,367 12,987 1,124,364 Todd C. Peterson, Ph.D. 12,837,656 13,698 1,124,364 Robin C. Kramer

            12,838,383       12,971          1,124,364

Proposal 2 - Advisory, non-binding vote on executive compensation:

The Company's stockholders approved, on an advisory, non-binding basis, the Company's executive officer compensation.

Vote For Votes Against Abstentions Broker Non-Votes 12,771,720 32,726 46,908 1,124,364

Proposal 3 - Non-binding advisory approval of the frequency of future advisory votes on the Company's named executive officer compensation:

The Company's stockholders approved, on an advisory basis, a one-year frequency for future advisory votes on the Company's named executive officer compensation.





  1 Year     2 Years   3 Years   Abstentions   Broker Non-Votes
11,704,578   899,965   224,260     22,551         1,124,364

After considering the results of the non-binding advisory vote on the frequency of future advisory votes on the Company's named executive officer compensation at the Annual Meeting, the Company's Board of Directors determined that the Company will hold an advisory vote on named executive compensation annually until the next required vote on the frequency of such votes.

Proposal 4 - Ratification of selection of Ernst & Young LLP as the independent registered public accounting firm:

The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.





 Vote For    Votes Against   Abstentions   Broker Non-Votes
13,948,254       8,904         18,560             0


 Item 8.01 Other Events.

On December 9, 2020, the Company issued a press release announcing the election of Robin C. Kramer to its Board of Directors. Following the Annual Meeting, the Board appointed Robin C. Kramer was appointed to serve as a director and as Chair of the Audit Committee.

The full text of the press release issued in connection with this announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.






  (d) Exhibits.




Exhibit No.   Description

  99.1          Press Release, dated December 9, 2020.

© Edgar Online, source Glimpses